Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2025-12-26 @ 2:49 AM
Study NCT ID:
NCT04823702
Status:
COMPLETED
Last Update Posted:
2022-01-19
First Post:
2021-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
Sponsor:
NGM Biopharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-26
First Submit QC Date:
None
Study First Post Date:
2021-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-15
Last Update Post Date:
2022-01-19
Last Update Post Date Type:
ACTUAL